Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TxCell SA TXCL Financial and Strategic SWOT Analysis Review Updated 15052017 Prices from USD $300

$
0
0
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells with focus on chronic inflammatory and autoimmune diseases. The company provides products for chronic inflam...

Viewing all articles
Browse latest Browse all 2985

Trending Articles